- Filed
- Nov 6, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q3 2024 · Sep 30, 2024 | $39.59M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $35.33M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $135.7M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $70.43M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $20.96M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $23.91M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $38.33M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $59.45M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $79.82M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $141.08M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $88.43M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $151.53M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 1.74M sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 1.73M sh |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$56.34M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $54.82M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $69.64M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $103.9M |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$10.37 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$34.59 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$10.37 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$34.59 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $6.44M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $24.2M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $15.87M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $50.78M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$18.04M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$59.79M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$19.07M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$62.13M |
| Revenue | Q3 2024 · Sep 30, 2023 | $1.09M |
| Revenue | Q3 2024 · Sep 30, 2023 | $5.52M |